Ibuprofen API Market Size

Ibuprofen API Market size was over USD 715.08 million in 2024 and is expected to cross USD 936.89 million by the end of 2037, growing at more than 2.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of ibuprofen API is estimated at USD 727.09 million.. The growth of the market is poised to be dominated by a surge in prevalence of influenza. For instance, according to the prediction of WHO every year, there are approximately a billion instances of seasonal influenza, with 3–5 million of those instances resulting in serious disease. Hence, ibuprofen API used with a mixture of acetaminophen is set to be increased to tackle this issue. These medications can relieve headaches and muscle aches in addition to lowering temperature. 

Additionally, the rise in COVID-19 cases is also projected to have a great influence on the ibuprofen API market over the coming years. Despite being primarily a respiratory illness, COVID-19 may demand a long time to be identified and require self-administered symptomatic treatment of its subtle and non-specific clinical course. Since one of the most typical signs of COVID-19 is fever, antipyretic drugs like ibuprofen are crucial for managing patients' symptoms.